NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
+8.83%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$681M
AUM Growth
+$681M
(+69%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
34.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$223M |
| 2 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$16.2M |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$3.22M |
Sector Composition
| 1 | Healthcare | 37.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $286M | 41.96% | 2,979,100 | – | – |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $223M | 32.76% | +6,896,819 | New | +$223M |
|
3
Vanguard FTSE Europe ETF
VGK
$26.8B
| $124M | 18.14% | 2,101,000 | – | – |
|
|
WMGI
4
DELISTED
Wright Medical Group Inc
WMGI
| $18M | 2.64% | 585,759 | – | – |
|
|
TTPH
5
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $16.2M | 2.38% | +1,200,000 | New | +$16.2M |
|
|
6
PTC Therapeutics
PTCT
$3.92B
| $12.8M | 1.88% | 597,359 -150,000 | -20% | -$3.22M |
|